COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma
- 28 February 2007
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 104 (2), 320-325
- https://doi.org/10.1016/j.ygyno.2006.08.044
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometriumInternational Journal of Gynecologic Cancer, 2006
- Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancerGynecologic Oncology, 2005
- Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometriumGynecologic Oncology, 2005
- Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: Tissue microarray analysisAmerican Journal of Obstetrics and Gynecology, 2005
- Role of cyclooxygenase‐2 in immunomodulation and prognosis of endometrial carcinomaInternational Journal of Cancer, 2005
- Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancersAnnals of Oncology, 2005
- COX‐2‐dependent stabilization of survivin in non‐small cell lung cancerThe FASEB Journal, 2003
- Cyclooxygenase‐2 expression in endometrial carcinomaCancer, 2002
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.JCI Insight, 1994